Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Pathways authored by Yamaguchi, Hirohito (9912204)
Pathways reviewed by Yamaguchi, Hirohito (9912204)
Details on Person Yamaguchi, Hirohito
| Class:Id | Person:9912204 |
| _displayName | Yamaguchi, Hirohito |
| _timestamp | 2025-08-26 07:58:33 |
| created | [InstanceEdit:9912244] Tiwari, Krishna, 2024-06-06 |
| crossReference | [DatabaseIdentifier:9965198] ORCID:0000-0003-0425-916X |
| firstname | Hirohito |
| initial | H |
| modified | [InstanceEdit:9912266] Tiwari, Krishna, 2024-06-06 [InstanceEdit:9965199] Matthews, Lisa, 2025-08-26 |
| surname | Yamaguchi |
| (author) | [LiteratureReference:9912160] Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics [LiteratureReference:9934258] Deubiquitination and Stabilization of PD-L1 by CSN5 [LiteratureReference:9934267] Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity [LiteratureReference:9935396] Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1 [LiteratureReference:9962759] MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1 [InstanceEdit:9964122] Hung, Mien-Chie, Yamaguchi, Hirohito, 2025-08-26 |
|
[Change default viewing format]
|